AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Momotaro-Gene Inc.
  3. Financials
  4. Cash and cash equivalents

Momotaro-Gene Inc.【JP:E33052】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 202367+0.55%
Mar 31, 202266-79.92%
Mar 31, 2021330-48.69%
Mar 31, 2020643-32.31%
Mar 31, 2019950+15.44%
Mar 31, 2018823-15.97%
Mar 31, 2017979+360.78%
Mar 31, 2016213+414.58%
Mar 31, 201541+448.81%
Mar 31, 20148-42.34%
Mar 31, 201313-47.78%
Mar 31, 201225+100.46%
Mar 31, 201112-46.24%
Mar 31, 201023-77.94%
Mar 31, 2009105

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)